Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
about
Differentiation of chronic lymphocytic leukemia B cells into immunoglobulin secreting cells decreases LEF-1 expression.Toll-like receptor 9 is required for opioid-induced microglia apoptosis.Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemiaToll-Like Receptors and Cancer: MYD88 Mutation and Inflammation.VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia.Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) StudyTLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence.Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells.The role of toll-like receptor 9 in chronic stress-induced apoptosis in macrophage.Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patientsInvolvement of the HCK and FGR src-family kinases in FCRL4-mediated immune regulationTLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphismCpG oligodeoxynucleotide CpG-685 upregulates functional interleukin-21 receptor on chronic lymphocytic leukemia B cells through an NF-κB mediated pathwayThe BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cellsTrial Watch: Experimental Toll-like receptor agonists for cancer therapyPhase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemiaTargeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia.Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironmentProlonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignanciesGIFT4 fusokine converts leukemic B cells into immune helper cellsAt High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia Cells.Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphomaToll-like receptor 9 is required for chronic stress-induced immune suppressionHeterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application.Toll-like Receptors in Chronic Lymphocytic Leukemia.Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia.Modeling the chronic lymphocytic leukemia microenvironment in vitro.Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia.Kinetic analysis of internalization of white spot syndrome virus by haemocyte subpopulations of penaeid shrimp, Litopenaeus vannamei (Boone), and the outcome for virus and cell.TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and ImmunityBrief report: serpin Spi2A as a novel modulator of hematopoietic progenitor cell formation.Extracellular vesicles released from chronic lymphocytic leukemia cells exhibit a disease relevant mRNA signature and transfer mRNA to bystander cells.Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic LeukemiaMyeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosis.Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.Association of self-DNA mediated TLR9-related gene, DNA methyltransferase, and cytokeratin protein expression alterations in HT29-cells to DNA fragment length and methylation status.
P2860
Q31038111-3B00D928-EBD8-4513-9A4C-0C7E5003A498Q33895294-FC154E3E-0995-481D-A95B-4C892BA76D38Q33910990-BB79E22A-3A14-49D9-A683-998CBB1472BDQ33978723-3AD657D0-0EF3-4D03-A51C-FC29D08D484FQ34382986-8342C7CD-C358-4A27-B58F-E4C1F55313FDQ34479465-3DA559A6-5447-45B2-9128-50634CBA1B83Q34880391-1580765B-D207-4AB6-9D32-256868F3AC2FQ35096709-3CB5173B-F7EC-4FBC-8AED-4711EE19B043Q35461779-F4CE78D4-5771-49DB-8905-0AB031B5E962Q35528659-FD0A3FCB-5DB8-4D8F-AB8C-25A7CF7006A8Q35686107-92FA3691-A7F7-4041-B948-575679149320Q35861964-F81F59C7-311B-46A0-8294-13A0FCAA0FB9Q36071989-D87ED112-F099-48A5-9342-CF498F71AF70Q36140670-D7C21253-7A4D-4313-A226-4BC68B046F19Q36165173-3C7AA7E9-A4CD-4AD0-A1CD-6A01B4171B74Q36194849-8EDB1726-9E17-4C81-ADF5-7DA3DF1C5E52Q36222910-BD635C9A-294D-4AB9-BE76-B2CD9A05E56CQ36512593-90AEC187-EB9A-47C7-9A5F-971268C13397Q36758769-11E1E991-3575-43F9-9448-4A9CC62D6821Q36802795-E33C3B3F-B478-4509-B18A-5A9D4E84B97BQ36842259-E858D22C-18AA-4E5A-82C8-3098EDB03EC2Q36906043-8764D30E-31C2-4FF2-8F64-CC515A60B880Q36979947-D4D4B24C-12B2-4CD3-9CDD-C5EF1F569B98Q37422510-C5941A89-CB85-4CE9-8AF0-B9AC44ACF7ECQ37498029-FAE4626F-A3C6-4806-8A1D-EA4A5086B202Q37671216-A72C0600-979F-4C8D-8AEB-E68242E60CFFQ38042942-E41219B2-FEE8-4F36-9F77-93B91A88359CQ38298483-41932F7E-46C3-4F8D-AB9A-F88081AC57D2Q38646974-05E8BC88-C6BC-435B-99CB-6213BC5E69A5Q38984569-0F5F9333-3DD8-47C9-B646-CEC472D2D98BQ39414732-11C3A1D8-781A-4423-81BF-9CFF86BE2C8AQ40499390-745EA452-02BE-4304-86D2-C24250712FE9Q41677234-415C0994-0EBB-4FF0-8A2C-C2791576BDDEQ41895673-E1C473DA-A299-483F-AABB-9DAEE8D763D9Q42361976-797C1457-C31A-4629-8421-B5421AF4C64FQ47212613-9E686ED4-7C29-4965-B4E1-F9F132DC5A24Q51712946-203CA611-97F7-4594-A1A0-C83DB4400C48Q52579132-9B6F5FDA-5B3C-4ED5-8A34-93DE15298366Q52649195-EC29483D-D66E-437B-82F3-EF4F90E46F2FQ54331419-4A14D606-578A-496E-B3B2-AD6E189F7521
P2860
Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Toll-like receptor 9 signaling ...... lymphocytic leukemia B cells.
@ast
Toll-like receptor 9 signaling ...... lymphocytic leukemia B cells.
@en
type
label
Toll-like receptor 9 signaling ...... lymphocytic leukemia B cells.
@ast
Toll-like receptor 9 signaling ...... lymphocytic leukemia B cells.
@en
prefLabel
Toll-like receptor 9 signaling ...... lymphocytic leukemia B cells.
@ast
Toll-like receptor 9 signaling ...... lymphocytic leukemia B cells.
@en
P2093
P2860
P921
P1433
P1476
Toll-like receptor 9 signaling ...... lymphocytic leukemia B cells.
@en
P2093
Daniel J Weisdorf
E Ashley Moseman
Michael A Farrar
Veronika Bachanova
Xueqing Liang
P2860
P304
P356
10.1182/BLOOD-2009-03-213363
P407
P577
2010-03-25T00:00:00Z